Skip to main content

Table 1 People with epilepsy and annual in-part requirement of PB across different divisions of Bhutan

From: Availability and sufficiency of phenobarbital, an essential medication, in Bhutan: a survey of global and neuropsychiatric relevance

Province Population PEP Target pop PB requirement/year (Kg) 3 Km (%) P/D
Bumthang 18,965 114 11 0.5 75 7715
Chhukha 88,342 530 53 2.1 NA 4908
Dagana 27,522 165 16 0.7 NA NA
Gasa 3,694 22 2 0.1 NA 3694
Haa 13,499 81 8 0.3 71 1227
Lhuentse 17,618 106 11 0.4 87 17,201
Monggar 44,259 266 27 1.1 89 2168
Paro 43,167 259 26 1.0 NA 10,415
Pemagatshel 25,176 151 15 0.6 68 8394
Punakha 17,715 106 11 0.4 NA NA
Samdrupjonkhar 39,961 240 24 1.0 NA NA
Samtse 60,100 361 36 1.4 NA NA
Sarpang 45,637 274 27 1.1 93 2985
Thimphu 98,676 592 59 2.4 94 1015
Trashigang 56,168 337 34 1.4 NA 9361
Trashiyangtse 20,874 125 12 0.5 72 5139
Trongsa 13,419 81 8 0.3 NA NA
Tsirang 18,667 112 11 0.4 NA NA
Wangdue 36,922 222 22 0.9 NA NA
Zhemgang 18,636 112 11 0.4 NA NA
  1. Annual requirement of PB100 mg tablets is based on prevalent lifetime epilepsy pool of patients. Target population was defined as treating 50.0% of the 20.0% of the prevalent epilepsy population (i.e. column 4)
  2. 3Km proportion of population within 3 Km walking distance, NA no information available, PEP prevalent epilepsy population, PB phenobarbital, P/D number of persons per doctor